In addition, loss or mutation of TP53 has also been linked to alterations in anti-tumor immunity (poor tumor immunogenicity and ultimately immune escape) as well as dysregulation of cell cycle and apoptosis (36, 37). This evidence concerns the gene TP53 and neoplasm.